New York Cancer & Blood Specialists Expands Care, Research to Port Jefferson Station

Friday, September 27, 2019

Having built a reputation for providing advanced care throughout the region, New York Cancer & Blood Specialists has further expanded its clinical and research footprint in Suffolk County with the opening of a Cancer Center in Port Jefferson Station.

Conveniently located at 49 Route 347, the new facility was christened on Aug. 5. It is the organization’s 15th Cancer Center in Suffolk County and its 30th in a broader area that also encompasses Bronx, Manhattan, Nassau County and Queens.

Patients at the Cancer Center benefit from comprehensive diagnosis, treatment and support services, as well as a wide range of cutting-edge technologies and access to an array of clinical trials.

“We have taken all of the experience we have gathered over the past 50 years of this practice taking care of patients in Suffolk County and used it to create this new center,” says Jeff Vacirca, MD, FACP, CEO of New York Cancer & Blood Specialists.

Treating the Whole Patient

The physical and psychological stressors associated with a cancer diagnosis are magnified when patients must travel to multiple treatment facilities scattered across a broad geographic area. The availability of multidisciplinary, wraparound care at the new Port Jefferson Station Cancer Center addresses those concerns proactively to alleviate the burden on patients.

Patients have ready access to board-certified oncologists and hematologists at the center. Also available on-site are diagnostic services, infusional therapy and advanced imaging modalities, including PET, CT, and the latest-generation MRI and ultrasound technologies. Social support services, psychological care, a pharmacy, nutritional consultation and other services are available as well to address the full spectrum of patients’ needs.

The construction of the facility less than a mile from New York Cancer & Blood Specialists’ state-of-the-art, CyberKnife-equipped Radiation Center provides convenient accessibility to additional advanced treatment.

“We’ve spent many years treating and listening to patients to understand their needs and have crafted a Cancer Center to give them top-quality treatment as well as all services under one roof. This is about creating the best patient experience possible.”
— Jeff Vacirca, MD, FACP, CEO of New York Cancer & Blood Specialists

On the Leading Edge of Care

Cancer patients outside major metropolitan areas often have little or no opportunity to participate in clinical trials that can provide early access to the most promising therapies. But high-level research is integral to the mission of the new Port Jefferson Station Cancer Center.

“We want to be able to offer the newest therapies to all of our patients on Long Island, and this is our starting point,” Dr. Vacirca notes. “With more than 50 clinical trials available, we can bring the newest and best drugs to our patients. This is a proud moment for those dedicated to comprehensive cancer care.”

Grammy-Nominated Artist Gavin DeGraw Helps Celebrate Grand Opening

Attendees at the Aug. 5 grand opening of New York Cancer & Blood Specialists’ new Cancer Center in Port Jefferson Station enjoyed a surprise performance by multiplatinum-selling singer and songwriter Gavin DeGraw to mark the occasion.

DeGraw, a South Fallsburg, New York, native, and Colbie Caillat earned a Grammy nomination in 2014 for their duet “We Both Know” from the film “Safe Haven.” DeGraw’s interest in helping move cancer research and treatment forward is personal: His mother died of pancreatic cancer.

“I’m excited to be here with all of you for the opening of this great building,” he said in a Long Island Press article. “I hope to see it do great things and help so many people.”

DeGraw’s performance at the center was the latest demonstration of his commitment to the fight against cancer. He has also partnered with the Lustgarten Foundation — a Woodbury, New York-based organization that funds pancreatic cancer research — to enhance public awareness of the disease.

For more information or to refer a patient to New York Cancer & Blood Specialists, visit